Pharmaceutical

Johnson & Johnson gains FDA and EC approvals for TB treatment

Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).

Jul 4, 2024 - 04:00
Johnson & Johnson gains FDA and EC approvals for TB treatment
Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (bedaquiline) to treat pulmonary tuberculosis (TB).
Read the original article

Tags:

Previous Article

Protecting your drug products: Strategies for preventing metal contamination in ...

Next Article

Moderna’s mRNA influenza vaccine receives $176m boost

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Microsoft strikes partnership with Duke Health to advance AI in medicine

STAT+: Microsoft strikes partnership with Duke Health t...

Aug 1, 2023

EMA starts review into hair loss drugs about potential link to suicidal thoughts 

EMA starts review into hair loss drugs about potential ...

Oct 8, 2024

New York’s new doula plan will cover services for anyone on Medicaid

New York’s new doula plan will cover services for anyon...

Jan 12, 2024